| Literature DB >> 16806674 |
Zhongming Zhang1, Keiichiro Joh, Hitomi Yatsuki, Wei Zhao, Hidenobu Soejima, Ken Higashimoto, Mitsuyo Noguchi, Masatoshi Yokoyama, Tsuyoshi Iwasaka, Tsunehiro Mukai.
Abstract
To elucidate the silencing mechanism of retinoic acid receptor beta2 (RAR beta2) in cervical carcinogenesis, we investigated RAR beta2 expression and the status of both DNA methylation and histone modifications at the promoter in cervical cancer cell lines. RAR beta2 was frequently repressed in cancer cell lines and in primary cancers of the cervix. Although the majority of RAR beta2-negative cancers had methylated promoter, RAR beta2 was repressed with hypomethylated promoter in a substantial fraction of the cancers. The RAR beta2-negative cells with hypomethylated promoters showed a repressive histone modification pattern at the promoter. RAR beta2 was reactivated by a histone deacetylase inhibitor, accompanied by formation of active histone modifications. The repressive modification was also observed in cells repressed with hypermethylated promoter, but RAR beta2 was reactivated only by DNA demethylating agent and not by histone deacetylase inhibitor. Our results suggest that RAR beta2 is silenced by either of the two key epigenetic pathways, DNA methylation or repressive histone modifications, depending on the individual cancer cells.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16806674 DOI： 10.1016/j.canlet.2006.05.013
Source DB: PubMed Journal: Cancer Lett ISSN： 0304-3835 Impact factor: 8.679